Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A new study ...

Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, with more than 6 million Americans aged 12 and older meeting the criteria for ...

—A team of researchers in Tokyo recently took on the challenge of attempting to determine whether comprehensive genomic profiling has clinical utility in a large cohort of patients with non-small cell ...

Today, healthcare is shifting away from a one-size-fits-all approach toward personalized medicine designed around each person’s genetics, lifestyle, and health history. At St. Elizabeth Healthcare, ...

Interpreting genomic test results for cancer care remains a significant challenge, with variability in turnaround times, reporting standards, and clinical utility impacting patient outcomes. As the ...

Genomic testing is pivotal in refining breast cancer treatment strategies, particularly for African American women facing unique diagnostic challenges. Tests like MAMMAPRINT analyze numerous genes, ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Genomic screening is rapidly moving from the margins of ...

Genetic testing identifies changes (mutations) in a dog’s DNA that can indicate a predisposition to certain genetic diseases or inherited disorders. The primary benefits include early disease ...

Groundbreaking research at Seattle Children's Hospital provides critical genetic diagnoses for newborns within 48 hours.